DK0869970T3 - Endothelcelleprolifereringsinhibitor og dens anvendelse - Google Patents
Endothelcelleprolifereringsinhibitor og dens anvendelseInfo
- Publication number
- DK0869970T3 DK0869970T3 DK96945635T DK96945635T DK0869970T3 DK 0869970 T3 DK0869970 T3 DK 0869970T3 DK 96945635 T DK96945635 T DK 96945635T DK 96945635 T DK96945635 T DK 96945635T DK 0869970 T3 DK0869970 T3 DK 0869970T3
- Authority
- DK
- Denmark
- Prior art keywords
- cell proliferation
- endothelial cell
- proliferation inhibitor
- inhibitor
- endothelial
- Prior art date
Links
- 230000004663 cell proliferation Effects 0.000 title abstract 3
- 210000002889 endothelial cell Anatomy 0.000 title abstract 3
- 239000003112 inhibitor Substances 0.000 title abstract 3
- 230000003511 endothelial effect Effects 0.000 abstract 1
- 238000000099 in vitro assay Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Plant Substances (AREA)
- Farming Of Fish And Shellfish (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US851995P | 1995-12-13 | 1995-12-13 | |
| US08/763,528 US5854221A (en) | 1996-12-12 | 1996-12-12 | Endothelial cell proliferation inhibitor and method of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0869970T3 true DK0869970T3 (da) | 2004-07-05 |
Family
ID=26678280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96945635T DK0869970T3 (da) | 1995-12-13 | 1996-12-13 | Endothelcelleprolifereringsinhibitor og dens anvendelse |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20010016644A1 (pt) |
| EP (1) | EP0869970B1 (pt) |
| JP (1) | JP3684371B2 (pt) |
| KR (1) | KR100477280B1 (pt) |
| CN (1) | CN1554444A (pt) |
| AT (1) | ATE262537T1 (pt) |
| AU (1) | AU710612B2 (pt) |
| BR (1) | BR9612115A (pt) |
| CA (1) | CA2240296C (pt) |
| CZ (1) | CZ298612B6 (pt) |
| DE (1) | DE69631972T2 (pt) |
| DK (1) | DK0869970T3 (pt) |
| ES (1) | ES2217340T3 (pt) |
| HK (1) | HK1017692A1 (pt) |
| HU (1) | HUP9900979A3 (pt) |
| NO (1) | NO321775B1 (pt) |
| NZ (1) | NZ330537A (pt) |
| PL (1) | PL188719B1 (pt) |
| PT (1) | PT869970E (pt) |
| WO (1) | WO1997023500A1 (pt) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ330537A (en) * | 1995-12-13 | 2001-06-29 | Childrens Medical Center | Kringle 5 rerion of plasminogen as an endothelial cell proliferation inhibitor |
| US5801146A (en) * | 1996-05-03 | 1998-09-01 | Abbott Laboratories | Compound and method for inhibiting angiogenesis |
| DE69733756T2 (de) * | 1996-05-03 | 2006-06-01 | Abbott Laboratories, Abbott Park | Antiangiogenische peptiden, dafür kodierende polynukleotide und verfahren zur hemmung der angiogenesis |
| US6699838B1 (en) | 1996-05-03 | 2004-03-02 | Abbott Laboratories | Antiangiogenic peptides |
| US5801012A (en) | 1996-09-17 | 1998-09-01 | Northwestern University | Methods and compositions for generating angiostatin |
| AU7951798A (en) * | 1997-06-26 | 1999-01-19 | Karolinska Innovations Ab | Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| WO1999026480A1 (en) * | 1997-11-20 | 1999-06-03 | Genetix Pharmaceuticals, Inc. | Anti-angiogenic gene therapy vectors and their use in treating angiogenesis-related diseases |
| US6632961B1 (en) | 1998-05-22 | 2003-10-14 | Abbott Laboratories | Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| US7144854B1 (en) | 1999-09-10 | 2006-12-05 | Conjuchem, Inc. | Long lasting anti-angiogenic peptides |
| CA2373252C (en) * | 1999-05-17 | 2007-08-07 | Conjuchem Inc. | Long lasting anti-angiogenic peptides |
| CA2501421A1 (en) | 1999-05-17 | 2000-11-23 | Conjuchem Inc. | Long lasting exendin-4 |
| CA2394167A1 (en) * | 1999-12-15 | 2001-06-21 | Entremed, Inc. | Compositions and methods for inhibiting endothelial cell proliferation |
| AU2001285919B2 (en) | 2000-09-05 | 2007-08-23 | Jiangsu Simcere Pharmaceutical R&D Co., Ltd | Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen |
| AU2002239414A1 (en) * | 2000-11-02 | 2002-05-27 | Bristol-Myers Squibb Company | Modified plasminogen related peptide fragments and their use as angiogenesis inhibitors |
| WO2005072341A2 (en) * | 2004-01-21 | 2005-08-11 | Fujirebio America, Inc. | Detection of mesothelin-/megakaryocyte potentiating factor-related peptides in peritoneal fluid for assessment of the peritoneum and the peritoneal cavity |
| CN100355458C (zh) * | 2005-03-16 | 2007-12-19 | 北京大学 | 人增殖抑制基因－腺病毒表达载体的应用 |
| US20120220015A1 (en) | 2009-05-26 | 2012-08-30 | Biolex Therapeutics | Compositions and methods for production of aglycosylated plasminogen |
| CN103060265B (zh) * | 2013-01-23 | 2014-12-03 | 山东大学 | 老年大鼠脑血管内皮细胞原代培养方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4929444A (en) * | 1985-05-28 | 1990-05-29 | Burroughs Wellcome Co. | Low pH pharmaceutical formulation containing t-PA |
| US5149533A (en) * | 1987-06-04 | 1992-09-22 | Zymogenetics, Inc. | Modified t-PA with kringle-/replaced by another kringle |
| US5302390A (en) * | 1987-07-01 | 1994-04-12 | Beecham Group Plc | Hybrid proteins of human plasminogen and human t-PA, pharmaceutical compositions and methods of treatment |
| US5491129A (en) * | 1992-07-30 | 1996-02-13 | Yeda Research And Development Co. Ltd. | Synthetic peptides derived from vitronectin and pharmaceutical compositions comprising them |
| WO1995029243A1 (en) * | 1994-04-26 | 1995-11-02 | Pharmacia & Upjohn Company | Mac-1 i-domain protein useful in blocking adhesion and migration of neutrophils |
| CA2188813C (en) * | 1994-04-26 | 2010-08-03 | Michael S. O'reilly | Angiostatin protein, nucleic acids encoding the same and methods of detection |
| DE69637179T2 (de) * | 1995-04-26 | 2008-04-10 | The Children's Medical Center Corp., Boston | Angiostatinfragmente und verfahren für deren verwendung |
| NZ330537A (en) * | 1995-12-13 | 2001-06-29 | Childrens Medical Center | Kringle 5 rerion of plasminogen as an endothelial cell proliferation inhibitor |
-
1996
- 1996-12-13 NZ NZ330537A patent/NZ330537A/en not_active IP Right Cessation
- 1996-12-13 AU AU16870/97A patent/AU710612B2/en not_active Ceased
- 1996-12-13 JP JP52383197A patent/JP3684371B2/ja not_active Expired - Fee Related
- 1996-12-13 PL PL96327200A patent/PL188719B1/pl unknown
- 1996-12-13 DK DK96945635T patent/DK0869970T3/da active
- 1996-12-13 HU HU9900979A patent/HUP9900979A3/hu unknown
- 1996-12-13 WO PCT/US1996/020447 patent/WO1997023500A1/en active IP Right Grant
- 1996-12-13 CN CNA2004100432779A patent/CN1554444A/zh active Pending
- 1996-12-13 CA CA002240296A patent/CA2240296C/en not_active Expired - Fee Related
- 1996-12-13 PT PT96945635T patent/PT869970E/pt unknown
- 1996-12-13 AT AT96945635T patent/ATE262537T1/de active
- 1996-12-13 BR BR9612115A patent/BR9612115A/pt not_active Application Discontinuation
- 1996-12-13 EP EP96945635A patent/EP0869970B1/en not_active Expired - Lifetime
- 1996-12-13 CZ CZ0182898A patent/CZ298612B6/cs not_active IP Right Cessation
- 1996-12-13 DE DE69631972T patent/DE69631972T2/de not_active Expired - Lifetime
- 1996-12-13 KR KR10-1998-0704447A patent/KR100477280B1/ko not_active IP Right Cessation
- 1996-12-13 ES ES96945635T patent/ES2217340T3/es not_active Expired - Lifetime
-
1998
- 1998-06-12 NO NO19982715A patent/NO321775B1/no not_active IP Right Cessation
-
1999
- 1999-06-23 HK HK99102688.5A patent/HK1017692A1/xx not_active IP Right Cessation
-
2000
- 2000-12-29 US US09/753,064 patent/US20010016644A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2240296C (en) | 2004-05-04 |
| NZ330537A (en) | 2001-06-29 |
| HK1017692A1 (en) | 1999-11-26 |
| PL327200A1 (en) | 1998-11-23 |
| HUP9900979A3 (en) | 2001-10-29 |
| PL188719B1 (pl) | 2005-04-29 |
| AU710612B2 (en) | 1999-09-23 |
| NO982715D0 (no) | 1998-06-12 |
| ES2217340T3 (es) | 2004-11-01 |
| DE69631972T2 (de) | 2005-01-05 |
| DE69631972D1 (de) | 2004-04-29 |
| CA2240296A1 (en) | 1997-07-03 |
| HUP9900979A2 (hu) | 1999-07-28 |
| EP0869970A1 (en) | 1998-10-14 |
| NO982715L (no) | 1998-08-12 |
| JP2002502359A (ja) | 2002-01-22 |
| CZ298612B6 (cs) | 2007-11-21 |
| US20010016644A1 (en) | 2001-08-23 |
| EP0869970B1 (en) | 2004-03-24 |
| JP3684371B2 (ja) | 2005-08-17 |
| KR100477280B1 (ko) | 2005-07-18 |
| KR19990072126A (ko) | 1999-09-27 |
| AU1687097A (en) | 1997-07-17 |
| BR9612115A (pt) | 1999-02-17 |
| NO321775B1 (no) | 2006-07-03 |
| PT869970E (pt) | 2004-08-31 |
| WO1997023500A1 (en) | 1997-07-03 |
| CZ182898A3 (cs) | 1998-10-14 |
| EP0869970A4 (en) | 2002-01-30 |
| ATE262537T1 (de) | 2004-04-15 |
| CN1554444A (zh) | 2004-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0869970T3 (da) | Endothelcelleprolifereringsinhibitor og dens anvendelse | |
| ATE183196T1 (de) | Peptidinhibitoren von fibronectin und verwandten kollagen-bindenden proteinen | |
| FI962350A (fi) | BPM-12, BMP-13 sekä niiden jännettä indusoivat koostumukset | |
| ATE172743T1 (de) | Nachweis von kollagenabbau -i(in vivo) | |
| ATE281469T1 (de) | Inhibitor des wachstumsfaktors für gefäss- endothelzellen | |
| BR9707049A (pt) | Agentes anticoagulantes utilizáveis no tratamento de trombose | |
| CY1107821T1 (el) | Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c | |
| TR199801255T2 (xx) | Vitronektin resept�r antagonistleri. | |
| ATE400289T1 (de) | Verwendung vom vaskulären endothelialen wachstumsfaktor 2 (vegf-2) | |
| NO960939L (no) | Kininogenaseinhibitor | |
| DK0830130T3 (da) | TNF-alfa-omdannende enzym | |
| DE59410132D1 (de) | Humanes zirkulierendes cytokin cc-1 | |
| NO961423D0 (no) | Oligopeptider avledet fra C-reaktive proteinfragmenter | |
| MX9205978A (es) | Nuevas proteinas inhibidoras de trombina de garrapatas. | |
| BR9407357A (pt) | Novos tripeptideos utilizáveis em terapia cns e imune | |
| FR2676059B1 (fr) | Nouveaux derives de peptides utilisables comme inhibiteurs de collagenases bacteriennes. | |
| ATE310083T1 (de) | Deprenyl induziertes protein | |
| FR2654430B1 (fr) | Nouveaux derives de peptides, utilisables comme inhibiteurs des collagenases bacteriennes. | |
| DE69530779D1 (de) | Muramylpeptide zusammensetzungen für inhibierung von hiv replikation | |
| MY106261A (en) | Anti-inflammatory 1-heteroaryl oxindole-3-carboxamides. | |
| RU95114125A (ru) | Ингибитор пролиферации стволовых кроветворных клеток |